2 Growth Stocks That Are Unapologetically Crushing the Bear Market
It's no surprise that investors covet stocks which can keep climbing when everything else in the market is going down. Most businesses don't have the special sauce that it takes to reassure shareholders in times of economic uncertainty, and the few that do are likely to have looming catalysts for higher earnings or access to cash-cow market segments that competitors don't -- or both.
In that vein, below are two biomedical growth stocks that are crushing the bear market. And both of these companies are primed for future success thanks to their upcoming milestones and strong earnings performance, so they might be of interest to long-term investors.
Buoyed by a slew of favorable clinical trial data readouts and success with regulators, Ionis Pharmaceuticals (NASDAQ: IONS) is up by 16% this year in comparison to the market's decline of more than 13%. Though the business has three medicines on the market and its latest quarterly revenue grew 27.2% year over year, it's narrowly unprofitable. But that might be changing relatively soon thanks to a particularly lucrative program approaching the end of its pivotal trials.
Source Fool.com
